About CareFusion (NYSE:CFN)
CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company’s primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
Trailing P/E Ratio25.5063829787234
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity12.80%
Return on Assets7.62%
CareFusion (NYSE:CFN) Frequently Asked Questions
What is CareFusion's stock symbol?
CareFusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFN."
How were CareFusion's earnings last quarter?
CareFusion Co. (NYSE:CFN) announced its quarterly earnings data on Thursday, February, 5th. The healthcare company reported $0.99 earnings per share for the quarter, topping analysts' consensus estimates of $0.79 by $0.20. The healthcare company earned $1.07 billion during the quarter, compared to analyst estimates of $1.01 billion. CareFusion had a net margin of 16.18% and a return on equity of 12.80%. The firm's revenue for the quarter was up 15.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.54 EPS. View CareFusion's Earnings History.
Who are some of CareFusion's key competitors?
Some companies that are related to CareFusion include C R Bard (BCR), Zimmer Biomet (ZBH), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), Steris (STE), Bio-Rad Laboratories (BIO), West Pharmaceutical Services (WST), Hill-Rom (HRC), DexCom (DXCM), Globus Medical (GMED), ICU Medical (ICUI), VWR (VWR), Integra Lifesciences (IART), LivaNova (LIVN), Haemonetics (HAE), Neogen (NEOG), Inogen (INGN) and NuVasive (NUVA).
How do I buy CareFusion stock?
Shares of CareFusion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CareFusion's stock price today?
One share of CareFusion stock can currently be purchased for approximately $59.94.
How big of a company is CareFusion?
CareFusion has a market capitalization of $12.24 billion.
How can I contact CareFusion?
CareFusion's mailing address is 3750 Torrey View Ct, SAN DIEGO, CA 92130-2622, United States. The healthcare company can be reached via phone at +1-800-6848880.
MarketBeat Community Rating for CareFusion (CFN)MarketBeat's community ratings are surveys of what our community members think about CareFusion and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
CareFusion (NYSE:CFN) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
CareFusion (NYSE:CFN) Earnings History and Estimates Chart
CareFusion (NYSE CFN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/5/2015||Q215||$0.79||$0.99||$1.01 billion||$1.07 billion||View||N/A|
|11/6/2014||Q115||$0.49||$0.50||$920.50 million||$922.00 million||View||N/A|
|8/7/2014||Q414||$0.72||$0.79||$1.04 billion||$1.12 billion||View||Listen|
|5/5/2014||Q314||$0.62||$0.60||$986.67 million||$968.00 million||View||Listen|
|2/3/2014||Q214||$0.54||$0.54||$911.13 million||$922.00 million||View||Listen|
|11/7/2013||Q1 2014||$0.40||$0.44||$817.82 million||$830.00 million||View||N/A|
|8/8/2013||Q4 2013||$0.56||$0.55||$918.25 million||$903.00 million||View||Listen|
|5/9/2013||Q3 2013||$0.53||$0.59||$909.16 million||$901.00 million||View||Listen|
CareFusion (NYSE:CFN) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for CareFusion (NYSE:CFN)
No dividend announcements for this company have been tracked by MarketBeat.com
CareFusion (NYSE CFN) Insider Trading and Institutional Ownership History
CareFusion (NYSE CFN) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/6/2015||Jonathan Wygant||CAO||Sell||1,700||$59.79||$101,643.00|| |
|2/6/2015||Philip L Francis||Director||Sell||40,980||$59.89||$2,454,292.20|| |
|12/15/2014||Thomas J Leonard||Insider||Sell||25,000||$58.87||$1,471,750.00|| |
|12/4/2014||Donald Abbey||EVP||Sell||1,000||$59.35||$59,350.00|| |
|11/12/2014||J Michael Losh||Director||Sell||12,630||$57.32||$723,951.60|| |
|10/6/2014||James F Hinrichs||CFO||Sell||20,000||$56.91||$1,138,200.00|| |
|10/6/2014||Thomas J Leonard||Insider||Sell||8,400||$57.16||$480,144.00|| |
|10/1/2014||James F Hinrichs||CFO||Sell||20,000||$45.07||$901,400.00|| |
|9/19/2014||Thomas J Leonard||Insider||Sell||16,600||$47.01||$780,366.00|| |
|9/15/2014||Thomas J Leonard||Insider||Sell||25,000||$46.17||$1,154,250.00|| |
|7/7/2014||Thomas J Leonard||Insider||Sell||1,250||$45.47||$56,837.50|| |
|7/1/2014||Thomas J Leonard||Insider||Sell||19,721||$45.00||$887,445.00|| |
|6/6/2014||James F Hinrichs||CFO||Sell||21,506||$44.07||$947,769.42|| |
|6/2/2014||Thomas J Leonard||Insider||Sell||1,250||$42.81||$53,512.50|| |
|5/29/2014||Fortune Gordon La||EVP||Sell||2,158||$42.61||$91,952.38|| |
|5/20/2014||Kieran Gallahue||CEO||Sell||100,000||$42.98||$4,298,000.00||305,122|| |
|5/19/2014||Fortune Gordon La||EVP||Sell||38,738||$42.70||$1,654,112.60||20,894|| |
|5/19/2014||Thomas Leonard||Insider||Sell||30,000||$42.89||$1,286,700.00||34,553|| |
|5/5/2014||Thomas Leonard||Insider||Sell||1,250||$39.06||$48,825.00||34,553|| |
|4/7/2014||Thomas Leonard||Insider||Sell||1,250||$40.05||$50,062.50||35,803|| |
|4/4/2014||Donald Abbey||EVP||Sell||10,076||$41.79||$421,076.04||28,143|| |
|3/3/2014||Thomas Leonard||Insider||Sell||1,250||$40.26||$50,325.00||37,053|| |
|2/5/2014||Philip Francis||Director||Buy||6,500||$38.61||$250,965.00||4,515|| |
|2/5/2014||Thomas Leonard||Insider||Sell||21,496||$38.24||$822,007.04||38,303|| |
|1/9/2014||Kieran Gallahue||CEO||Sell||25,000||$41.05||$1,026,250.00||122,873|| |
|1/6/2014||Thomas Leonard||Insider||Sell||1,250||$39.48||$49,350.00||59,799|| |
|12/2/2013||James Hinrichs||CFO||Sell||28,078||$40.13||$1,126,770.14||27,024|| |
|12/2/2013||Kieran Gallahue||CEO||Sell||25,000||$40.09||$1,002,250.00||147,873|| |
|12/2/2013||Thomas Leonard||Insider||Sell||1,250||$39.99||$49,987.50||61,049|| |
|11/4/2013||Thomas J Leonard||Insider||Sell||1,250||$39.06||$48,825.00|| |
|10/1/2013||Thomas J Leonard||Insider||Sell||1,250||$36.99||$46,237.50|| |
|9/9/2013||Fortune Gordon La||EVP||Sell||33,960||$36.55||$1,241,238.00|| |
|9/3/2013||Thomas Leonard||Insider||Sell||1,250||$35.70||$44,625.00||64,799|| |
|8/26/2013||J Michael Losh||Director||Sell||53,311||$35.67||$1,901,603.37||32,858|| |
CareFusion (NYSE CFN) News Headlines
CareFusion (NYSE:CFN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
CareFusion (NYSE:CFN) Income Statement, Balance Sheet and Cash Flow Statement
CareFusion (NYSE CFN) Stock Chart for Friday, February, 23, 2018